![System.Func`1[System.String]](/siteassets/images/z-mckesson-logosicons/health-systems2.png)
One of our McKesson experts discusses the importance of staying informed as 340B changes continue to unfold.
Health System C-Suite Considerations: Exploring Innovative Partnerships with Your Distributor
Three key benefits of exploring nontraditional partnerships with your distributor to achieve more.
By
Date
January 27, 2025
Read Time
2 minutes
As a health system C-Suite executive, you may be tasked with navigating today’s unique challenges and creating a customized plan for your hospital that helps to ensure financial stability and the ability to continue delivering exceptional patient care. Much like a patient care plan, this should involve close collaboration between all stakeholders and external partners as well. But in an area as complex as the health system pharmacy – which can generate critical revenue for your health system at a time its needed most – you may need more than a traditional consultant. As McKinsey and Company recommends, exploring innovative and nontraditional partnerships with your distributor can help:
Identify new revenue opportunities
Insulate your health system from certain financial risks
Elevate the patient experience
At McKesson, our Professional & Advisory Services (P&AS) team is committed to helping you achieve more for the business of pharmacy with our experts’ strong clinical and business industry backgrounds, unique problem-solving acumen, and holistic approach to mitigating your health system’s most important pain points. Learn more about the benefits of partnering with our P&AS advisors here, or contact us directly at pas@mckesson.com.
Subscribe Now
To learn how McKesson can help health systems achieve more, sign up to have the Prescribed Perspectives newsletter delivered directly to your inbox.
Related Stories
The most downloaded content by health system pharmacy leaders in August 2025.
With available labor resources dwindling and a shrinking pipeline, health systems must find creative solutions for better using the personnel and partnerships they have.
At this year's event, our experts heard from health systems who may be underutilizing available tools and resources in 340B program management.
Click through this interactive experience for a closer look at what you can expect at this year’s HealthTrust University Conference.
Expert insights into prioritizing 340B as a system-wide program in your health system.
Our experts continue shaping industry conversations through regular conference and event engagements, like the HealthTrust University 340B Summit.
The most downloaded content by health system pharmacy leaders in July 2025.
McKesson’s Head of Cell, Gene, and Advanced Therapies discusses opportunities and challenges with CGT in the health system.
This interactive experience highlights key aspects of our SPE solutions, designed to help your health system achieve more.